Increased degradation of type I collagen in acne fulminans

Acta Dermato-Venereologica

Volumn 76, Issue 2, 1996, Pages 123-125

  Oikarinen, A ^a   Autio, P ^b   Karvonen, S L ^a   Risteli, J ^a   Reunala, T ^b  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1;

ACNE FULMINANS; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; COMPLICATION; CONTROLLED STUDY; HUMAN; MALE; OSTEOLYSIS; PRIORITY JOURNAL;

ACNE VULGARIS; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BONE DISEASES; CASE-CONTROL STUDIES; COLLAGEN; HUMANS; MALE; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 0029983160     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Karvonen S-L. Acne fulminans: report of clinical findings and treatment of twenty-four patients. J Am Acad Dermatol 1993; 28: 572-579.
2. Kelly AP, Burns RE. Acute febrile ulcerative acne with polyarthralgia. Arch Dermatol 1971; 104: 182-187.
3. Leiferman KM, Groover RV, Dicken CH. Acne fulminans and myositis. Cutis 1984; 34: 249-251.
4. Jemec GBE, Rasmussen I. Bone lesions of acne fulminans. J Am Acad Dermatol 1989; 20: 353-357.
5. Nault P, Lassonde M, St-Antoine P. Acne fulminans with osteolytic lesions. Arch Dermatol 1985; 121: 662-664.
6. O'Malley BP, Anderson I, Rosenthal FD. Bone lesions in systemic acne (acne fulminans). Br J Dermatol 1979; 100: 703-705.
7. Pauli S-L, Kokko ML, Suhonen R, Reunala T. Acne fulminans with bone lesions. Acta Derm Venereol (Stockh) 1988; 68: 351-355.
8. Laasonen LS, Karvonen S-L, Reunala T. Bone disease in adolescents with acne fulminans and severe cystic acne: radiographic and scintigraphic findings. Am J Roentgenol 1994; 162: 1161-1165.
9. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993; 39: 635-640.
10. Elomaa I, Virkkunen P, Risteli L, Risteli J. Serum concentration of the cross-linked carboxyterminal telopeptide of type collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer 1992; 66: 337-341.
11. Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease. Correlation to bone histomorphometry. J Bone Miner Res 1993; 8: 127-132.
12. Hakala M, Risteli L, Manelius J, Nieminen P, Risteli J. Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis. Ann Rheum Dis 1993; 52: 866-869.
13. Melkko J, Niemi S, Risteli L, Risteli J. Radioimmunoassay for the carboxyterminal propeptide of human type I procollagen. Clin Chem 1990; 36: 328-332.
14. Autio P, Risteli J, Palatsi R, et al. Effects of systemic isotretinoin on serum markers of collagen synthesis and degradation. Acta Derm Venereol (Stockh) 1993; 73: 108-112.
15. Karvonen S-L, Vaalasti A, Kautiainen H, Reunala T. Systemic corticosteroid and isotretinoin treatment in cystic acne. Acta Derm Venereol (Stockh) 1993; 73: 452-455.
16. Risteli L, Risteli J. Biochemical markers of bone metabolism. Ann Med 1993; 25: 385-393.